Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 1/20 | 0.51 |
| ▸ | BACE1 | P56817 | 1/20 | 0.51 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.51 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.51 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.51 |
| ▸ | XDH | P47989 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | SLCO1B3 | Q9NPD5 | 4/20 | 0.45 |
| ▸ | SLCO1B1 | Q9Y6L6 | 4/20 | 0.45 |
| ▸ | SLCO2B1 | O94956 | 3/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27013475 | 0.87 | ESR1 (0.68) | PDPK1ESR1PRKCABACE1PRKCQ | |
| SCHEMBL27006405 | 0.87 | ESR1 (0.68) | PDPK1ESR1PRKCABACE1PRKCQ | |
| SCHEMBL28910074 | 0.86 | BACE1 (0.48) | PDPK1ESR1PRKCABACE1PRKCQ | |
| SCHEMBL13750522 | 0.76 | ALDH1A1 (0.63) | XDHALDH1A1SLCO1B3SLCO1B1SLCO2B1 | |
| Neophellamuretin SCHEMBL30766255 | 0.74 | ABCG2 (0.66) | PDPK1ESR1PRKCABACE1PRKCQ | |
| Neophellamuretin SCHEMBL27013455 | 0.74 | ABCG2 (0.66) | PDPK1ESR1PRKCABACE1PRKCQ | |
| SCHEMBL30641793 | 0.72 | CBS (0.67) | XDHALDH1A1SLCO1B3SLCO1B1SLCO2B1 | |
| SCHEMBL28684198 | 0.72 | CBS (0.67) | XDHALDH1A1SLCO1B3SLCO1B1SLCO2B1 | |
| SCHEMBL31190926 | 0.72 | CBS (0.67) | XDHALDH1A1SLCO1B3SLCO1B1SLCO2B1 | |
| Kushenol N SCHEMBL564366 | 0.69 | BACE1 (0.73) | PDPK1ESR1PRKCABACE1PRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100256082-A1 | Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties | VIAMET PHARMACEUTICALS, INC. (US) | 2010-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100256082-A1 | Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties | MMEL1, MPI, METAP1 | PDPK1 3412/4885ESR1 3130/4885PRKCA 4661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.